Lifeworks Advisors LLC Has $677,000 Stock Position in Corteva, Inc. (NYSE:CTVA)

Lifeworks Advisors LLC reduced its holdings in Corteva, Inc. (NYSE:CTVA) by 21.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 11,507 shares of the company’s stock after selling 3,235 shares during the period. Lifeworks Advisors LLC’s holdings in Corteva were worth $677,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Capital International Investors increased its position in shares of Corteva by 2.6% during the first quarter. Capital International Investors now owns 26,437,457 shares of the company’s stock worth $1,524,648,000 after buying an additional 678,722 shares during the period. Van ECK Associates Corp increased its position in shares of Corteva by 2.5% during the third quarter. Van ECK Associates Corp now owns 8,902,675 shares of the company’s stock worth $541,194,000 after buying an additional 213,872 shares during the period. Bank of New York Mellon Corp increased its position in shares of Corteva by 28.4% during the second quarter. Bank of New York Mellon Corp now owns 6,842,907 shares of the company’s stock worth $369,106,000 after buying an additional 1,514,954 shares during the period. Legal & General Group Plc increased its position in shares of Corteva by 0.9% during the second quarter. Legal & General Group Plc now owns 6,741,972 shares of the company’s stock worth $363,662,000 after buying an additional 61,127 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of Corteva by 5.1% during the second quarter. Dimensional Fund Advisors LP now owns 4,649,450 shares of the company’s stock worth $250,786,000 after buying an additional 224,423 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Down 0.5 %

CTVA opened at $57.40 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.50 and a quick ratio of 0.96. The company’s 50-day moving average is $58.29 and its 200 day moving average is $55.65. Corteva, Inc. has a fifty-two week low of $43.89 and a fifty-two week high of $63.75. The firm has a market capitalization of $39.45 billion, a P/E ratio of 57.98, a PEG ratio of 1.85 and a beta of 0.77.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.18%. The ex-dividend date of this dividend is Monday, December 2nd. Corteva’s payout ratio is currently 68.69%.

Analyst Upgrades and Downgrades

CTVA has been the subject of several recent analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Corteva from $57.00 to $55.00 and set a “neutral” rating for the company in a research report on Friday, August 2nd. Argus lowered shares of Corteva from a “buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Bank of America raised shares of Corteva from a “neutral” rating to a “buy” rating and increased their target price for the stock from $59.00 to $67.00 in a research note on Wednesday, October 16th. Royal Bank of Canada cut their target price on shares of Corteva from $69.00 to $68.00 and set an “outperform” rating on the stock in a research note on Monday. Finally, UBS Group increased their target price on shares of Corteva from $67.00 to $71.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and an average price target of $63.68.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.